![](/img/cover-not-exists.png)
JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability
Morton, M. F., Barrett, T. D., Freedman, J., Li, L., Rizzolio, M. C., Prendergast, C. E., Wu, X., Moreno, V., Pyati, J., Figueroa, K., Cagnon, L., Lagaud, G., Ver Donck, L., Ghoos, E., Allison, B., RaVolume:
338
Language:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.110.178483
Date:
July, 2011
File:
PDF, 1.71 MB
english, 2011